David A. Siegel Delcath Systems, Inc. Transaction History

Two Sigma Advisers, LP

  • $42.5 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$5.64 - $7.95 $111,108 - $156,615
-19,700 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$7.2 - $11.72 $53,280 - $86,728
-7,400 Reduced 27.31%
19,700 $153,000
Q3 2021

Nov 15, 2021
SELL
$8.44 - $12.65 $70,896 - $106,260
-8,400 Reduced 23.66%
27,100 $283,000
Q2 2021

Aug 16, 2021
BUY
$9.54 - $15.1 $338,669 - $536,050
35,500 New
35,500 $448,000

Others Institutions Holding DCTH

# of Institutions
40
Shares Held
7.37M
Call Options Held
143K
Put Options Held
60.8K
View Full List

About DELCATH SYSTEMS, INC.

DCTH Quotes by TradingView
  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $72M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email